CD22, Human (Epratuzumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-CD22, Human (Epratuzumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityCD22, Human (Epratuzumab biosimilar)
CloneEpratuzumab
Host SpeciesRecombinant Mouse
Reactive Specieshuman
IsotypeIgG1
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
ApplicationsIF, IP, Neut, FuncS, ELISA, FCM, ICC, Activ, WB
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human CD22 Recombinant Antibody (Epratuzumab). Epratuzumab (planned trade name LymphoCide) is a humanized monoclonal antibody. Potential uses may be found in oncology and in treatment of inflammatory autoimmune disorders, such as systemic lupus erythematosus (SLE).
Immunogenn/a
Other NamesAnti-CD22 Recombinant Antibody, Research Grade Epratuzumab, Anti-Human CD22 Recombinant Antibody(Epratuzumab), 90Y-DOTA-hLL2, Antibody Drug Analogues, Monoclonal Antibody, YR1021, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 205923-57-5
Catalog #YR1021
Priceplease inquire
Order / More InfoCD22, Human (Epratuzumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.